(a) Arthritis score of hind paws in a mouse CIA model. Experimental arthritis was induced by two immunizations with collagen and CFA. Mice were administered vehicle, TAS5315, or prednisolone (Pred) once daily for 21 days from the 11th day after the second immunization (day 1). (b) Representative images of the right hind paw obtained by micro-CT on days 1, 8, 14, and 22. (c) The vertical axis depicts BMD values as determined by micro-CT analysis of both hind paws. Data are presented as mean ± SEM (n = 6–12 per group). *PPP<0.001 compared with the vehicle group (Steel test for TAS5315 groups, Wilcoxon test for Pred group).</p
<p>A) Scheme representing the experimental protocol followed, which is described in material and met...
<p>Both the arthritis score and the incidence of arthritis were reduced in CIA mice given AEBS. Mice...
<p>(A) Time schedule for induction of CAIA and treatment with MSCs. CAIA mice received two intraperi...
(a) Arthritis score in the mouse CIA model. Experimental arthritis was induced by two immunizations ...
(a, b) Experimental arthritis induced by two immunizations with collagen and CFA. After therapeutic ...
(a) Arthritis score in the CIA mouse model on day 15. Experimental arthritis induced by two immuniza...
(a, b) BTK occupancy by TAS5315 in PBMCs from rats at 6 h after administration. BTK that was not occ...
<p>A) Inhibition of arthritis in the CIA model. Mean clinical score of each group (n = 12), shown as...
<p>The incidence of arthritis (A), the hind paw clinical score (B) and the hind paw thickness (C) in...
<p>The data are presented as arthritis score of s.c. treated CIA mice, measured from day (0) (diseas...
<p><b>A</b>. Hindpaw thickness was measured bilaterally every day following serum injection on day 0...
<p>A) Evaluation of the increase of the paw swelling of CIA control mice or mice injected with synge...
Mean clinical severity score of mice induced with CIA demonstrating a consistent level of moderate a...
<p>Allo-tDCs were stimulated by LPS and pulsed with either CII peptide, OVA (as an irrelevant antige...
<p>(<b>A</b>) Bodyweight (<b>B</b>) thymus weight (<b>C</b>) AUC of the overall arthritis score (<b>...
<p>A) Scheme representing the experimental protocol followed, which is described in material and met...
<p>Both the arthritis score and the incidence of arthritis were reduced in CIA mice given AEBS. Mice...
<p>(A) Time schedule for induction of CAIA and treatment with MSCs. CAIA mice received two intraperi...
(a) Arthritis score in the mouse CIA model. Experimental arthritis was induced by two immunizations ...
(a, b) Experimental arthritis induced by two immunizations with collagen and CFA. After therapeutic ...
(a) Arthritis score in the CIA mouse model on day 15. Experimental arthritis induced by two immuniza...
(a, b) BTK occupancy by TAS5315 in PBMCs from rats at 6 h after administration. BTK that was not occ...
<p>A) Inhibition of arthritis in the CIA model. Mean clinical score of each group (n = 12), shown as...
<p>The incidence of arthritis (A), the hind paw clinical score (B) and the hind paw thickness (C) in...
<p>The data are presented as arthritis score of s.c. treated CIA mice, measured from day (0) (diseas...
<p><b>A</b>. Hindpaw thickness was measured bilaterally every day following serum injection on day 0...
<p>A) Evaluation of the increase of the paw swelling of CIA control mice or mice injected with synge...
Mean clinical severity score of mice induced with CIA demonstrating a consistent level of moderate a...
<p>Allo-tDCs were stimulated by LPS and pulsed with either CII peptide, OVA (as an irrelevant antige...
<p>(<b>A</b>) Bodyweight (<b>B</b>) thymus weight (<b>C</b>) AUC of the overall arthritis score (<b>...
<p>A) Scheme representing the experimental protocol followed, which is described in material and met...
<p>Both the arthritis score and the incidence of arthritis were reduced in CIA mice given AEBS. Mice...
<p>(A) Time schedule for induction of CAIA and treatment with MSCs. CAIA mice received two intraperi...